TABLE 2.
DHPS genotype | Nucleotide at position (amino acid): |
No. of patients positive/total no. of patients (%) (n = 151) | |
---|---|---|---|
165 (55) | 171 (57) | ||
Wild type | A (Thr) | C (Pro) | 66/151 (44) |
Mutant genotype, total | 85/151 (56) | ||
Single mutation | 36/85 (42) | ||
Position 165 (M1) | G (Ala) | C (Pro) | 4/85 (5) |
M1 + wild type | G/A (Ala/Thr) | C (Pro) | 15/85 (18) |
Position 171 (M2) | A (Thr) | T (Ser) | 7/85 (8) |
M2 + wild type | A (Thr) | T/C (Ser/Pro) | 10/85 (12) |
Double mutation | 18/85 (21) | ||
Positions 165 + 171 (M3) | G (Ala) | T (Ser) | 15/85 (18) |
M3 + M1 | G (Ala) | T/C (Ser/Pro) | 1/85 (1) |
M3 + M2 | G/A (Ala/Thr) | T (Ser) | 2/85 (2) |
Mixed genotypesa | G/A (Ala/Thr) | T/C (Ser/Pro) | 31/85 (36) |
Mixed infections in which the presence of mutants with double mutations and the wild type and/or a mixture of mutants with single mutations could not be resolved.